Picture of Novacyt SA logo

NCYT — Novacyt SA Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapContrarian

Momentum

Relative Strength (%)
1m+0.22%
3m-31.37%
6m-55.72%
1yr-60.19%
Volume Change (%)
10d/3m-69.97%
Price vs... (%)
52w High-69.45%
50d MA-9.69%
200d MA-37.14%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)1.79
PEG Ratio (f)n/a
EPS Growth (f)-62.21%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.76
Price to Tang. Book0.9
Price to Free Cashflow1.66
Price to Sales0.41
EV to EBITDA0.28

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital72.11%
Return on Equity85.49%
Operating Margin41.24%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Novacyt SA EPS forecast chart

Profile Summary

Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
July 3rd, 2006
Public Since
October 12th, 2012
No. of Employees
174
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
70,623,176

NCYT Share Price Performance

Latest News for NCYT

Upcoming Events for NCYT

Half Year 2022 Novacyt SA Earnings Release

Similar to NCYT

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email